A/APublished research associates this genotype with typical/baseline likelihood of Fasting blood glucose — no copies of the reported risk allele.
A/TPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Fasting blood glucose.
T/TPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Fasting blood glucose compared to the general population.
Nature genetics · 2010 · PMID 20081858 · open access
Questions about rs11920090
What is rs11920090?
rs11920090 is a single position in the genome, in or near the SLC2A2 gene. Published research associates it with fasting blood glucose. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs11920090 linked to?
On MyGeneLog this position is linked to Fasting Blood Glucose. The research behind each link, and its sources, are set out on that condition page.
Does rs11920090 affect how medicines work?
SLC2A2 carries pharmacogenomic findings for Metformin. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.
Does having rs11920090 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs11920090 come from?
GWAS Catalog, Nat Genet 2010, PMID:20081858. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.